Baxter International Inc (BAX) : Marathon Trading Investment Management added new position in Baxter International Inc during the most recent quarter end. The investment management firm now holds 615,000 shares of Baxter International Inc which is valued at $28 Million , the company said in a statement filed on May 13, 2016 with the SEC.Baxter International Inc makes up approximately 32.47% of Marathon Trading Investment Management’s portfolio.
Other Hedge Funds, Including , Renaissance Technologies boosted its stake in BAX in the latest quarter, The investment management firm added 24,900 additional shares and now holds a total of 517,032 shares of Baxter International Inc which is valued at $23.5 Million. Baxter International Inc makes up approx 0.04% of Renaissance Technologies’s portfolio.Bahl Gaynor Inc boosted its stake in BAX in the latest quarter, The investment management firm added 130 additional shares and now holds a total of 24,506 shares of Baxter International Inc which is valued at $1.1 Million. Baxter International Inc makes up approx 0.01% of Bahl Gaynor Inc’s portfolio.Gamco Investors Et Al reduced its stake in BAX by selling 3,150 shares or 2.01% in the most recent quarter. The Hedge Fund company now holds 153,750 shares of BAX which is valued at $6.9 Million. Baxter International Inc makes up approx 0.05% of Gamco Investors Et Al’s portfolio.Andra Ap-fonden boosted its stake in BAX in the latest quarter, The investment management firm added 6,900 additional shares and now holds a total of 271,700 shares of Baxter International Inc which is valued at $12.2 Million. Baxter International Inc makes up approx 0.33% of Andra Ap-fonden’s portfolio.
Baxter International Inc closed down -0.16 points or -0.37% at $43.5 with 1,07,47,349 shares getting traded on Wednesday. Post opening the session at $43.93, the shares hit an intraday low of $43.16 and an intraday high of $43.93 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
On the company’s financial health, Baxter International Inc reported $0.36 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 26, 2016. Analyst had a consensus of $0.29. The company had revenue of $2375.00 million for the quarter, compared to analysts expectations of $2351.22 million. The company’s revenue was down -1.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.00 EPS.
Investors should note that on May 3, 2016, Baxter International Inc announced a cash dividend of $0.1300. The company’s management has announced Jun 1, 2016 as the ex-dividend date and fixed the record date on Jun 3, 2016. The payable date has been fixed on Jul 1, 2016.
Many Wall Street Analysts have commented on Baxter International Inc. Company shares were Reiterated by RBC Capital Mkts on Apr 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 47 from a previous price target of $40 .Baxter International Inc was Upgraded by Piper Jaffray to ” Overweight” on Apr 14, 2016.
Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.